Outset Medical (OM) Competitors

$3.86 +0.14 (+3.76%)

Closing price 05/19/2026 04:00 PM Eastern

Extended Trading

$3.86 0.00 (-0.13%)

As of 05/19/2026 06:49 PM Eastern

OM vs. TLSI, SI, SGHT, CARL, and PROF

Should you buy Outset Medical stock or one of its competitors? MarketBeat compares Outset Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Outset Medical include TriSalus Life Sciences (TLSI), Shoulder Innovations (SI), Sight Sciences (SGHT), Carlsmed (CARL), and Profound Medical (PROF). These companies are all part of the "medical equipment" industry.

How does Outset Medical compare to TriSalus Life Sciences?

Outset Medical (NASDAQ:OM) and TriSalus Life Sciences (NASDAQ:TLSI) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment and earnings.

In the previous week, TriSalus Life Sciences had 6 more articles in the media than Outset Medical. MarketBeat recorded 11 mentions for TriSalus Life Sciences and 5 mentions for Outset Medical. TriSalus Life Sciences' average media sentiment score of 0.66 beat Outset Medical's score of 0.13 indicating that TriSalus Life Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Outset Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
TriSalus Life Sciences	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Outset Medical has a beta of 1.92, suggesting that its share price is 92% more volatile than the broader market. Comparatively, TriSalus Life Sciences has a beta of 0.56, suggesting that its share price is 44% less volatile than the broader market.

Outset Medical currently has a consensus target price of $10.00, indicating a potential upside of 159.07%. TriSalus Life Sciences has a consensus target price of $7.50, indicating a potential upside of 138.10%. Given Outset Medical's stronger consensus rating and higher probable upside, equities analysts plainly believe Outset Medical is more favorable than TriSalus Life Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
TriSalus Life Sciences	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

TriSalus Life Sciences has lower revenue, but higher earnings than Outset Medical. TriSalus Life Sciences is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$119.48M	0.60	-$81.65M	-$4.16	N/A
TriSalus Life Sciences	$45.15M	4.28	-$39.23M	-$1.41	N/A

TriSalus Life Sciences has a net margin of -60.85% compared to Outset Medical's net margin of -63.65%. TriSalus Life Sciences' return on equity of 0.00% beat Outset Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Outset Medical	-63.65%	-56.13%	-27.45%
TriSalus Life Sciences	-60.85%	N/A	-69.91%

2.6% of TriSalus Life Sciences shares are held by institutional investors. 2.5% of Outset Medical shares are held by insiders. Comparatively, 16.3% of TriSalus Life Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

TriSalus Life Sciences beats Outset Medical on 9 of the 16 factors compared between the two stocks.

How does Outset Medical compare to Shoulder Innovations?

Shoulder Innovations (NYSE:SI) and Outset Medical (NASDAQ:OM) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, media sentiment, institutional ownership and risk.

In the previous week, Shoulder Innovations had 4 more articles in the media than Outset Medical. MarketBeat recorded 9 mentions for Shoulder Innovations and 5 mentions for Outset Medical. Shoulder Innovations' average media sentiment score of 0.41 beat Outset Medical's score of 0.13 indicating that Shoulder Innovations is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Shoulder Innovations	1 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Outset Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Shoulder Innovations currently has a consensus target price of $21.00, suggesting a potential upside of 40.53%. Outset Medical has a consensus target price of $10.00, suggesting a potential upside of 159.07%. Given Outset Medical's higher probable upside, analysts clearly believe Outset Medical is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Shoulder Innovations has higher earnings, but lower revenue than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shoulder Innovations	$47.32M	6.55	-$40.36M	-$166.96	N/A
Outset Medical	$119.48M	0.60	-$81.65M	-$4.16	N/A

Outset Medical has a net margin of -63.65% compared to Shoulder Innovations' net margin of -81.78%. Shoulder Innovations' return on equity of -35.11% beat Outset Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shoulder Innovations	-81.78%	-35.11%	-20.58%
Outset Medical	-63.65%	-56.13%	-27.45%

Summary

Shoulder Innovations beats Outset Medical on 9 of the 13 factors compared between the two stocks.

How does Outset Medical compare to Sight Sciences?

Outset Medical (NASDAQ:OM) and Sight Sciences (NASDAQ:SGHT) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, profitability, analyst recommendations, risk, valuation and dividends.

In the previous week, Outset Medical had 2 more articles in the media than Sight Sciences. MarketBeat recorded 5 mentions for Outset Medical and 3 mentions for Sight Sciences. Sight Sciences' average media sentiment score of 0.73 beat Outset Medical's score of 0.13 indicating that Sight Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Outset Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Sight Sciences	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Sight Sciences has lower revenue, but higher earnings than Outset Medical. Sight Sciences is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$119.48M	0.60	-$81.65M	-$4.16	N/A
Sight Sciences	$77.36M	3.32	-$38.43M	-$0.71	N/A

55.5% of Sight Sciences shares are owned by institutional investors. 2.5% of Outset Medical shares are owned by insiders. Comparatively, 28.9% of Sight Sciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Outset Medical presently has a consensus price target of $10.00, indicating a potential upside of 159.07%. Sight Sciences has a consensus price target of $8.31, indicating a potential upside of 76.11%. Given Outset Medical's higher possible upside, equities analysts clearly believe Outset Medical is more favorable than Sight Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Sight Sciences	1 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.44

Sight Sciences has a net margin of -46.83% compared to Outset Medical's net margin of -63.65%. Sight Sciences' return on equity of -52.34% beat Outset Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Outset Medical	-63.65%	-56.13%	-27.45%
Sight Sciences	-46.83%	-52.34%	-28.49%

Outset Medical has a beta of 1.92, indicating that its share price is 92% more volatile than the broader market. Comparatively, Sight Sciences has a beta of 2.38, indicating that its share price is 138% more volatile than the broader market.

Summary

Sight Sciences beats Outset Medical on 11 of the 16 factors compared between the two stocks.

How does Outset Medical compare to Carlsmed?

Outset Medical (NASDAQ:OM) and Carlsmed (NASDAQ:CARL) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability, media sentiment and analyst recommendations.

Outset Medical presently has a consensus price target of $10.00, indicating a potential upside of 159.07%. Carlsmed has a consensus price target of $19.33, indicating a potential upside of 71.24%. Given Outset Medical's higher possible upside, research analysts plainly believe Outset Medical is more favorable than Carlsmed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Carlsmed	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Carlsmed has lower revenue, but higher earnings than Outset Medical. Carlsmed is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$119.48M	0.60	-$81.65M	-$4.16	N/A
Carlsmed	$50.51M	6.08	-$29.63M	-$2.51	N/A

In the previous week, Outset Medical had 5 more articles in the media than Carlsmed. MarketBeat recorded 5 mentions for Outset Medical and 0 mentions for Carlsmed. Carlsmed's average media sentiment score of 1.89 beat Outset Medical's score of 0.13 indicating that Carlsmed is being referred to more favorably in the news media.

Company	Overall Sentiment
Outset Medical	Neutral
Carlsmed	Very Positive

Carlsmed has a net margin of -57.76% compared to Outset Medical's net margin of -63.65%. Outset Medical's return on equity of -56.13% beat Carlsmed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Outset Medical	-63.65%	-56.13%	-27.45%
Carlsmed	-57.76%	-60.74%	-29.84%

Summary

Outset Medical beats Carlsmed on 6 of the 11 factors compared between the two stocks.

How does Outset Medical compare to Profound Medical?

Profound Medical (NASDAQ:PROF) and Outset Medical (NASDAQ:OM) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership.

In the previous week, Outset Medical had 3 more articles in the media than Profound Medical. MarketBeat recorded 5 mentions for Outset Medical and 2 mentions for Profound Medical. Profound Medical's average media sentiment score of 0.60 beat Outset Medical's score of 0.13 indicating that Profound Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Profound Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Outset Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Profound Medical has a beta of 0.73, meaning that its stock price is 27% less volatile than the broader market. Comparatively, Outset Medical has a beta of 1.92, meaning that its stock price is 92% more volatile than the broader market.

47.9% of Profound Medical shares are held by institutional investors. 1.5% of Profound Medical shares are held by insiders. Comparatively, 2.5% of Outset Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profound Medical presently has a consensus target price of $12.00, indicating a potential upside of 78.31%. Outset Medical has a consensus target price of $10.00, indicating a potential upside of 159.07%. Given Outset Medical's stronger consensus rating and higher possible upside, analysts plainly believe Outset Medical is more favorable than Profound Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Profound Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Profound Medical has higher earnings, but lower revenue than Outset Medical. Profound Medical is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Profound Medical	$16.10M	15.19	-$42.57M	-$1.24	N/A
Outset Medical	$119.48M	0.60	-$81.65M	-$4.16	N/A

Outset Medical has a net margin of -63.65% compared to Profound Medical's net margin of -206.76%. Outset Medical's return on equity of -56.13% beat Profound Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Profound Medical	-206.76%	-78.88%	-64.06%
Outset Medical	-63.65%	-56.13%	-27.45%

Summary

Outset Medical beats Profound Medical on 11 of the 16 factors compared between the two stocks.

Get Outset Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OM vs. The Competition

Export

Metric	Outset Medical	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$68.96M	$1.42B	$6.25B	$12.23B
Dividend Yield	N/A	N/A	2.80%	5.32%
P/E Ratio	-0.93	65.26	20.79	25.05
Price / Sales	0.60	6.01	531.21	72.69
Price / Cash	N/A	22.74	43.09	54.25
Price / Book	0.64	5.91	9.81	6.83
Net Income	-$81.65M	-$54.76M	$3.55B	$335.69M
7 Day Performance	-0.77%	1.74%	-2.12%	-2.15%
1 Month Performance	-16.27%	3.27%	-4.14%	-2.47%
1 Year Performance	-80.22%	-7.29%	28.34%	27.13%

Outset Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OM Outset Medical	2.0994 of 5 stars	$3.86 +3.8%	$10.00 +159.1%	-80.3%	$68.96M	$119.48M	N/A	520
TLSI TriSalus Life Sciences	3.4921 of 5 stars	$4.56 +0.4%	$7.00 +53.5%	-39.2%	$279.57M	$45.15M	N/A	106	News Coverage Insider Trade Gap Up
SI Shoulder Innovations	4.0355 of 5 stars	$13.36 +1.0%	$21.00 +57.2%	N/A	$276.85M	$47.32M	N/A	61	Earnings Report
SGHT Sight Sciences	4.175 of 5 stars	$4.93 -7.2%	$8.31 +68.6%	+44.3%	$268.24M	$77.36M	N/A	210
CARL Carlsmed	3.2654 of 5 stars	$9.83 +1.8%	$19.33 +96.7%	N/A	$267.18M	$50.51M	N/A	100

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OM) was last updated on 5/20/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Outset Medical (OM) Competitors

OM vs. TLSI, SI, SGHT, CARL, and PROF

How does Outset Medical compare to TriSalus Life Sciences?

Summary

How does Outset Medical compare to Shoulder Innovations?

Summary

How does Outset Medical compare to Sight Sciences?

Summary

How does Outset Medical compare to Carlsmed?

Summary

How does Outset Medical compare to Profound Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OM vs. The Competition

Outset Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Outset Medical (OM) Competitors

OM vs. TLSI, SI, SGHT, CARL, and PROF

How does Outset Medical compare to TriSalus Life Sciences?

Does the media favor OM or TLSI?

Which has more volatility & risk, OM or TLSI?

Do analysts prefer OM or TLSI?

Which has preferable valuation and earnings, OM or TLSI?

Is OM or TLSI more profitable?

Do institutionals and insiders have more ownership in OM or TLSI?

Summary

How does Outset Medical compare to Shoulder Innovations?

Does the media refer more to SI or OM?

Do analysts prefer SI or OM?

Which has better valuation and earnings, SI or OM?

Is SI or OM more profitable?

Summary

How does Outset Medical compare to Sight Sciences?

Does the media prefer OM or SGHT?

Which has preferable valuation & earnings, OM or SGHT?

Do institutionals and insiders believe in OM or SGHT?

Do analysts prefer OM or SGHT?

Is OM or SGHT more profitable?

Which has more risk & volatility, OM or SGHT?

Summary

How does Outset Medical compare to Carlsmed?

Do analysts rate OM or CARL?

Which has higher valuation and earnings, OM or CARL?

Does the media favor OM or CARL?

Is OM or CARL more profitable?

Summary

How does Outset Medical compare to Profound Medical?

Does the media favor PROF or OM?

Which has more risk and volatility, PROF or OM?

Do institutionals and insiders have more ownership in PROF or OM?

Do analysts recommend PROF or OM?

Which has stronger earnings and valuation, PROF or OM?

Is PROF or OM more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OM vs. The Competition

Outset Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools